CommentShaping the renaissance of psychedelic research
References (13)
- et al.
Development of a rational scale to assess the harm of drugs of potential misuse
Lancet
(2007) Acute adverse reactions to LSD in clinical and experimental use in the United Kingdom
Br J Psychiatry
(1971)Can psychedelics have a role in psychiatry again?
Br J Psychiatry
(2005)- et al.
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer
Arch Gen Psychiatry
(2011) - et al.
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
J Clin Psychiatry
(2006) - et al.
Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence
J Psychoactive Drugs
(2007)
Cited by (48)
Psychedelic drugs for psychiatric disorders
2022, Journal of the Neurological SciencesCitation Excerpt :These findings may exemplify some of the challenges in psychedelic research, including masking interventions due to unique psychoactive effects of psychedelics. For the same reason, the use of placebos remains a challenge, and evidence suggests that research participants and investigators can often predict treatment allocation accurately, even when controlled for active placebos [99–102]. Highly structured study settings and intensive psychosocial and behavioral interventions may also favor psychedelic interventions, especially in non-controlled studies.
Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review
2021, Journal of Psychiatric ResearchA review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses
2020, Journal of the Neurological SciencesCitation Excerpt :In the 1980s, rigorous research combining new techniques in molecular biology and neuroimaging began anew in a few laboratories. The decade saw the rise of multiple non-profit organizations promoting psychedelic research, including the Multidisciplinary Association for Psychedelic Studies (MAPS), the Heffter Research Institute, and the Beckley Foundation, all funded by private donors and organizations outside of government structure [8]. Unlike clinical trials conducted in the 1960s that were often uncontrolled and unblinded with inconsistent methods, contemporary psychedelic studies are carefully designed and subjected to strict approval process by Institutional Review Boards.
The Rising Use of LSD among Business Managers
2024, Substance Use and MisusePsilocybin’s effects on cognition and creativity: A scoping review
2023, Journal of Psychopharmacology